Supernus Pharmaceuticals | Stammkapital



Ordinary Share Capital Veränderung Datum
Abbott USD 25.15B 133M 2024-12
ANI Pharmaceuticals USD 2K 0 2024-12
Aurora Cannabis CAD 6.98B 907K 2024-12
Bristol-Myers Squibb USD 292M 0 2024-12
Canopy Growth CAD 8.67B 179.82M 2024-12
Corcept Therapeutics USD 136K 1000 2024-12
Eisai JPY 44.99B 0 2024-12
Eli Lilly USD 592.4M 1.5M 2024-12
Indivior 62M 3M 2024-12
Novo Nordisk 446M 0 2024-09
Pacira USD 47K 0 2024-12
Perrigo USD 6.73B 30M 2024-12
Pfizer USD 480M 0 2024-12
Supernus Pharmaceuticals USD 56K 1000 2024-12
United Therapeutics USD 800K 100K 2024-12
Xeris Pharmaceuticals USD 15K 0 2024-12



Supernus Pharmaceuticals Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.